Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery

Exclusion Criteria

• •Patients under topical or systemic anti- inflammatory drugs Patients with a concomitant diagnosis of glaucoma, or on therapy with antiglaucoma drugs
• •Patients on systemic or local therapy with drugs that alter the secretion of the tear film (beta blockers, antidepressants and psychotropics)
• •Patients with a history of allergic, congenital, autoimmune systemic diseases
• •Patients who have undergone previous eye surgery
• •Ocular or peri-ocular malignancies or premalignant conditions
• •Active or suspected ocular or peri-ocular infection.
• •Complicated Cataract Surgery
• •Patients with a positive pregnancy testAllergy or reaction history to study drug
• •Patients who participated in a clinical trial in which an investigational drug was administered within 30 days or 5 half-lives of the study drug